Home › Compare › IGXT vs VICI

IGXT vs VICI: Dividend Comparison 2026

IGXT yields 1176.47% · VICI yields 5.88%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IGXT wins by $78814195.17M in total portfolio value
10 years
IGXT
IGXT
● Live price
1176.47%
Share price
$0.17
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$78814195.20M
Annual income
$67,523,701,253,088.38
Full IGXT calculator →
VICI
VICI Properties Inc.
● Live price
5.88%
Share price
$28.90
Annual div
$1.70
5Y div CAGR
8.1%
Payout ratio
74%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$2,376.06
Full VICI calculator →

Portfolio growth — IGXT vs VICI

📍 IGXT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIGXTVICI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IGXT + VICI cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
IGXT pays
VICI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IGXT
Annual income on $10K today (after 15% tax)
$100,000.00/yr
After 10yr DRIP, annual income (after tax)
$57,395,146,065,125.13/yr
VICI
Annual income on $10K today (after 15% tax)
$500.00/yr
After 10yr DRIP, annual income (after tax)
$2,019.65/yr
At 15% tax rate, IGXT beats the other by $57,395,146,063,105.48/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IGXT + VICI for your $10,000?

IGXT: 50%VICI: 50%
100% VICI50/50100% IGXT
Portfolio after 10yr
$39407097.62M
Annual income
$33,761,850,627,732.22/yr
Blended yield
85.67%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

IGXT
Analyst Ratings
2
Buy
Consensus: Buy
Altman Z
-23.8
Piotroski
4/9
VICI
Analyst Ratings
20
Buy
6
Hold
Consensus: Buy
Price Target
$31.60
+9.3% upside vs current
Range: $30.00 — $33.00
Altman Z
1.4
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IGXT buys
0
VICI buys
0
No recent congressional trades found for IGXT or VICI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIGXTVICI
Forward yield1176.47% ✓5.88%
Annual dividend / share$2.00 ✓$1.70
Payout ratio50% ✓74%
1-year div growth0%6.3% ✓
5-year div CAGR0%8.1% ✓
Portfolio after 10y$78814195.20M ✓$30.3K
Annual income after 10y$67,523,701,253,088.38 ✓$2,376.06
Total dividends collected$77969765.27M ✓$13.2K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy

Year-by-year: IGXT vs VICI ($10,000, DRIP)

YearIGXT PortfolioIGXT Income/yrVICI PortfolioVICI Income/yrGap
1← crossover$128,347$117,647.06$11,056$635.88+$117.3K → IGXT
2$1,548,514$1,411,182.61$12,250$729.34+$1.54M → IGXT
3$17,569,052$15,912,142.01$13,602$838.33+$17.56M → IGXT
4$187,523,354$168,724,468.35$15,139$965.75+$187.51M → IGXT
5$1,883,716,681$1,683,066,692.55$16,890$1,115.11+$1883.70M → IGXT
6$17,816,329,317$15,800,752,468.33$18,890$1,290.64+$17816.31M → IGXT
7$158,731,384,105$139,667,911,735.60$21,181$1,497.50+$158731.36M → IGXT
8$1,332,782,916,056$1,162,940,335,063.89$23,813$1,741.95+$1332782.89M → IGXT
9$10,551,863,503,163$9,125,785,782,982.70$26,845$2,031.67+$10551863.48M → IGXT
10$78,814,195,201,473$67,523,701,253,088.38$30,348$2,376.06+$78814195.17M → IGXT

IGXT vs VICI: Complete Analysis 2026

IGXT — Stock

IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine; INT0046/2018 for adult use; INT0007/2006, an oral film product for treatment of erectile dysfunction; INT0043/2015, an oral film containing montelukast for treatment of Alzheimer; INT0027/2011 to treat opioid addition; INT0010/2006 for treatment of neuropathic pain and nausea in cancer patients undergoing chemotherapy; INT0036/2013, an oral film product for schizophrenia or bipolar 1 disorder; and INT0048/2020 for animal health. It is also developing INT0039/2013, INT0040/2014, INT0052/2020, INT0053/2020, and INT0054/2020. The company has licensing, development, and supply agreement with Tilray, Inc.; and development agreement with Cynapsus Therapeutics Inc. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada.

Full IGXT Calculator →

VICI — REIT

VICI Properties is a gaming and entertainment REIT owning properties including Caesars Palace and MGM Grand in Las Vegas. Its triple-net leases with leading casino operators provide highly predictable income. VICI has grown its dividend 8%+ annually since its 2018 IPO, making it one of the fastest-growing REITs.

Full VICI Calculator →
📬

Get this IGXT vs VICI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IGXT vs SCHDIGXT vs JEPIIGXT vs OIGXT vs KOIGXT vs MAINIGXT vs NNNIGXT vs EPRTIGXT vs ADC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.